CLINICAL RESEARCH: CORONARY ARTERY DISEASE AND CARDIAC METABOLISM
The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women
Brendan M. Everett, MD*, , , ,*,
Tobias Kurth, MD, ScD*,||,¶,
Julie E. Buring, ScD*,,,|| and
Paul M. Ridker, MD, MPH, FACC*,,,||
* Division of Preventive Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Donald W. Reynolds Cardiovascular Clinical Research Center on Atherosclerosis at Brigham and Women’s Hospital and the Harvard Medical School, Boston, Massachusetts
|| Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts
¶ Division of Aging, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
Manuscript received June 20, 2006;
revised manuscript received September 6, 2006,
accepted September 11, 2006.
* Reprint requests and correspondence: Dr. Brendan M. Everett, Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, 900 Commonwealth Avenue East, Boston, Massachusetts 02215. (Email: beverett{at}partners.org).
OBJECTIVES: We sought to determine the relative strength of high-sensitivity C-reactive protein (hs-CRP) and lipid levels as markers for future ischemic stroke compared with coronary heart disease (CHD) in women.
BACKGROUND: Although hs-CRP and lipid levels are established risk determinants for vascular disease, the relative strength of these biomarkers for ischemic stroke compared with CHD is uncertain.
METHODS: Among 15,632 initially healthy women who were followed for a 10-year period, we compared hs-CRP, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), non–high-density lipoprotein cholesterol (non-HDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoproteins A-I and B100, and lipid ratios as determinants of ischemic stroke compared with CHD.
RESULTS: After adjustment for age, smoking status, blood pressure, diabetes, and obesity, the hazard ratios (HRs) and 95% confidence intervals (CIs) for the third versus the first tertile for future ischemic stroke compared with CHD were, respectively, 1.91 (95% CI 1.13 to 3.21) and 2.26 (95% CI 1.64 to 3.12) for TC, 1.29 (95% CI 0.83 to 2.02) and 2.09 (95% CI 1.53 to 2.85) for LDL-C, 0.57 (95% CI 0.36 to 0.92) and 0.38 (95% CI 0.27 to 0.52) for HDL-C, 1.72 (95% CI 1.03 to 2.86) and 2.93 (95% CI 2.04 to 4.21) for non–HDL-C, and 2.76 (95% CI 1.51 to 5.05) and 1.66 (95% CI 1.17 to 2.34) for hs-CRP. Of the lipid ratios, that of TC to HDL-C had the largest HR for both future ischemic stroke and CHD (HR 1.95 [95% CI 1.16 to 3.26] and 4.20 [95% CI 2.79 to 6.32], respectively).
CONCLUSIONS: In this large prospective cohort of initially healthy women, lipid levels are significant risk determinants for ischemic stroke, but with a magnitude of effect smaller than that observed for CHD. High-sensitiviy CRP associates more closely with ischemic stroke than with CHD. Concomitant evaluation of lipid levels and hs-CRP may improve risk assessment for stroke as well as CHD. (The Women’s Health Study; http://www.clinicaltrials.gov/ct/show/NCT00000479/; NCT00000479
[ClinicalTrials.gov]
)
|
Abbreviations and Acronyms
| | ARIC = Atherosclerosis Risk in Communities | | CHD = coronary heart disease | | CI = confidence interval | | HDL-C = high-density lipoprotein cholesterol | | HR = hazard ratio | | hs-CRP = high-sensitivity C-reactive protein | | LDL-C = low-density lipoprotein cholesterol | | LR = likelihood ratio | | TC = total cholesterol | | WHS = Women’s Health Study |
|
This article has been cited by other articles:
|
|
|
|
 
M.S.V. Elkind, J. M. Luna, Y. P. Moon, K. M. Liu, S. L. Spitalnik, M. C. Paik, and R. L. Sacco
High-sensitivity C-reactive protein predicts mortality but not stroke: The Northern Manhattan Study
Neurology,
October 20, 2009;
73(16):
1300 - 1307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. I. Buckley, R. Fu, M. Freeman, K. Rogers, and M. Helfand
C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force
Ann Intern Med,
October 6, 2009;
151(7):
483 - 495.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Helfand, D. I. Buckley, M. Freeman, R. Fu, K. Rogers, C. Fleming, and L. L. Humphrey
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Ann Intern Med,
October 6, 2009;
151(7):
496 - 507.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Karelina, G. J. Norman, N. Zhang, J. S. Morris, H. Peng, and A. C. DeVries
Social isolation alters neuroinflammatory response to stroke
PNAS,
April 7, 2009;
106(14):
5895 - 5900.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M Ridker
C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease
Clin. Chem.,
February 1, 2009;
55(2):
209 - 215.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Zacho, A. Tybjaerg-Hansen, J. S. Jensen, P. Grande, H. Sillesen, and B. G. Nordestgaard
Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
N. Engl. J. Med.,
October 30, 2008;
359(18):
1897 - 1908.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Schunkert and N. J. Samani
Elevated C-Reactive Protein in Atherosclerosis -- Chicken or Egg?
N. Engl. J. Med.,
October 30, 2008;
359(18):
1953 - 1955.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Schurks, R. Y.L. Zee, J. E. Buring, and T. Kurth
Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease
Neurology,
August 12, 2008;
71(7):
505 - 513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Welsh, G. D.O. Lowe, J. Chalmers, D. J. Campbell, A. Rumley, B. C. Neal, S. W. MacMahon, and M. Woodward
Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke
Stroke,
August 1, 2008;
39(8):
2226 - 2230.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Sangle, R. J. Davies, M. Mora, M. A. Baron, G. R. V. Hughes, and D. P. D'Cruz
Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis
Rheumatology,
July 1, 2008;
47(7):
1058 - 1060.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J.P. Kastelein, W. A. van der Steeg, I. Holme, M. Gaffney, N. B. Cater, P. Barter, P. Deedwania, A. G. Olsson, S. M. Boekholdt, D. A. Demicco, et al.
Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment
Circulation,
June 10, 2008;
117(23):
3002 - 3009.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Ridker
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward Consensus
J. Am. Coll. Cardiol.,
May 29, 2007;
49(21):
2129 - 2138.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
